ARCHIVES

SWOG, NCI Canada halt two large trials of Iressa for non-small cell lung cancer.

This article is from The Cancer Letter archive.

Vol. 31 No. 16 | April 22, 2005

Download PDF Visit The Full Archive

Related Articles

FDA Committee Approves Two NDAs, Blocks One, Hears NCI Toxicology Plan

June 15, 1979

Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival

March 28, 2014

DCIS With Higher Density May Increase Risk For Disease

October 29, 2010

Hope for FDA authority over tobacco products dies in Congress.

October 15, 2004

Pres. Bill Clinton to Serve as Honorary Chair Of NBCC’s Breast Cancer Deadline 2020

November 16, 2012

FCRC Committee Limited To Review Of Basic Science

November 26, 1976